Carregant...

Targeted proteomics for validation of biomarkers in clinical samples

The rapid rise and application of proteomic technologies has resulted in an exponential increase in the number of proteins that have been discovered and presented as ‘potential’ biomarkers for specific diseases. Unfortunately, the number of biomarkers approved for use by the Food and Drug Administra...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ye, Xiaoying, Blonder, Josip, Veenstra, Timothy D.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2009
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2722261/
https://ncbi.nlm.nih.gov/pubmed/19109305
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/bfgp/eln050
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!